Rezolute, Inc. — Director's Dealing 2014

Jul 25, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AntriaBio, Inc. (FMYY)
CIK: 0001509261
Period of Report: 2014-07-18

Reporting Person: Sherman Barry Michael (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to purchase Common Stock	$1.84	2021-07-18	Common Stock (75000)		Direct

Footnotes

F1: Pursuant to the terms of the Reporting Person's option to purchase common stock ("Common Stock Option"), 1/48th of the Common Stock Option will vest on August 31, 2014, with the remaining Common Stock Option to vest monthly over the forty-seven months thereafter.